Furthermore, early indications of a strong anti-inflammatory potential were found, especially via the regulation of NF-κB (Tyagi et al., 2017), which is mainly responsible for inflammation, with high relevance in acute and chronic inflammations, and resulting cancers (Fauve et al., 1974; Libermann and Baltimore, 1990; Neurath et al., 1996). The gene discussed is NFKB1; the disease is cancer.